Neurotropic B vitamins effects: overview
DOI: 10.32364/2587-6821-2023-7-10-6
A.L. Vertkin, G.Yu. Knorring, Z.K. Aliev
A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
The importance of pain syndromes is obvious not only medically but also socially. Dissatisfaction with the pain relief efficacy, a variety of pathogenetic mechanisms dictate the need to search for new and/or additional analgesics. Previously, the role of neurotropic B vitamins, potentiating analgesic therapy, and having their base potential, including additional effects, was convincingly shown. However, the role of vitamins in this group turned out to be much more important and covers a wide range of vital aspects of the body functioning as a whole and the nervous system in particular. The article considers the importance of vitamins in the following: ensuring the energy metabolism of nervous tissue, regulation of neurons key processes, key neurotransmitters metabolism, structural components, as well as removal of neurotoxic substances. The article also emphasizes synergistic, cooperative effect of these vitamins, as well as it describes their role in the normal state and in the pathology development, including those mediated by vitamin deficiencies. The available data on the use of the entire B vitamins palette, both experimental and clinical, in the treatment of pain syndromes, pathology of the central and peripheral nervous system is analyzed.
Keywords: pain, nervous system, neurodegeneration, B vitamins, thiamine, riboflavin, pyridoxine, folic acid, cyanocobalamin.
For citation: Vertkin A.L., Knorring G.Yu., Aliev Z.K. Neurotropic B vitamins effects: overview. Russian Medical Inquiry. 2023;7(10):650–657 (in Russ.). DOI: 10.32364/2587-6821-2023-7-10-6.
About the authors:
Arkadiy L. Vertkin — Dr. Sc. (Med.), Professor, Head of the Department of Therapy, Clinical Pharmacology, & Emergency, A.I. Yevdokimov Moscow State University of Medicine and Dentistry; 20/1, Delegatskaya str., Moscow, 127473, Russian Federation; ORCID iD 0000-0001-8975-8608.
German Yu. Knorring — C. Sc. (Med.), associate professor of the Department of Therapy, Clinical Pharmacology, and Emergency, A.I. Yevdokimov Moscow State University of Medicine and Dentistry; 20/1, Delegatskaya str., Moscow, 127473, Russian Federation; ORCID iD 0000-0003-4391-2889.
Zaur K. Aliev — assistant of the Department of Therapy, Clinical Pharmacology, & Emergency, A.I. Yevdokimov Moscow State University of Medicine and Dentistry; 20/1, Delegatskaya str., Moscow, 127473, Russian Federation. Contact information: German Yu. Knorring, e-mail: knorring@mail.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 19.07.2023.
Revised 11.08.2023.
Accepted 05.09.2023.
References
1. Stochkendahl M.J., Kjaer P., Hartvigsen J. et al. National clinical guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018;27(1):60–75. DOI: 10.1007/s00586-017-5099-2.
2. 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, аnd years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. DOI: 10.1016/S0140-6736(18)32279-7.
3. Верткин А.Л., Шамуилова М.М., Кнорринг Г.Ю. и др. Профилактика и лечение боли в спине: Консенсусы экспертов. Доктор.Ру. 2020;19(9):45–52. [Vertkin A.L., Shamuilova M.M., Knorring G.Yu. Prevention and Treatment of Back Pain: Experts' Consensus Recommendations. Doctor.Ru. 2020;19(9):45–52 (in Russ.)]. DOI: 10.31550/1727-2378-2020-19-9-45-52.
4. Самарцев И.Н., Живолупов С.А., Баранцевич Е.Р., Данилов А.Б. Оценка терапевтической эффективности Алфлутопа в комплексном лечении пациентов с хронической болью в нижней части спины (наблюдательное исследование ЦЕЙТНОТ). Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(2):24–30. DOI: 10.17116/jnevro202112102124. [Samartcev I.N., Zhivolupov S.A., Barantsevich E.R., Danilov AB. The evaluation of the efficacy of Alflutop in the complex treatment of patients with chronic lower back pain (the observational study ZEITNOT). Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2021;121(2):24–30 (in Russ.)]. DOI: 10.17116/jnevro202112102124.
5. Скоромец А.А., Гехт А.Б., Галанов Д.В. и др. Результаты международного фармако-эпидемиологического наблюдательного проекта по применению мидокалма для лечения болевых синдромов, сопровождающихся мышечным спазмом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;115(12):104–109. DOI: 10.17116/jnevro2015115112104-109. [Skoromets A.A., Guekht A.B., Galanov D.V. et al. The results of the multicenter pharmaco-epidemiological observational project on the use of mydocalm in the treatment of pain syndromes with the muscle spasm. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015;115(12):104–109 (in Russ.)]. DOI: 10.17116/jnevro2015115112104-109.
6. Верткин А.Л., Каратеев А.Е., Кукушкин М.Л. и др. Ведение пациентов с болью в спине для терапевтов и врачей общей практики (клинические рекомендации). Терапия. 2018;2(20):8–17. [Vyortkin A.L., Karateev A.E., Kukushkin M.L. et al. Curation of patients with back pain for physicians and general practitioners (Clinical recommendations).Therapy. 2018;2(20):8–17 (in Russ.)].
7. Каратеев А.Е., Лила А.М., Дыдыкина И.С. и др. Персонификация применения нестероидных противовоспалительных препаратов при скелетно-мышечных заболеваниях. Резолюция по результатам совещания экспертов от 13 декабря 2017 г. Медицинский совет. 2018;18:76-84. DOI: 10.21518/2079-701X-2018-18-76-84. [Karateev A.E., Lila A.M., Dydykina I.S. et al. Personalization of the use of non-steroidal anti-inflammatory drugs for musculoskeletal diseases. Resolution on the results of the Meeting of Experts of December 13, 2017. Medical Council. 2018;(18):76–84 (in Russ.)]. DOI: 10.21518/2079-701X-2018-18-76-84.
8. Кукушкин М.Л. Алгоритмы диагностики и лечения боли в спине. РМЖ. 2014;11:844–848. [Kukushkin M.L. Algorithms for diagnosing and treating back pain. RMJ. 2014;11:844–848 (in Russ.)].
9. Кнорринг Г.Ю., Алиев З.К. Комбинированная терапия болевых синдромов: обоснование и перспективы потенцирования эффектов. Медицинский алфавит. 2020;1(1):28–30. DOI: 10.33667/2078-5631-2020-1-28-30. [Knorring G.Yu., Aliev Z.K. Combined therapy of pain syndromes: rationale and prospects for potentiation of effects. Medical alphabet. 2020;1(1):28–30 (in Russ.)]. DOI: 10.33667/2078-5631-2020-1-28-30.
10. Kuhlwein A., Meyer H.J., Koehler C.O. Ersparung von Diclofenac durch B-Vitamine: Ergebnisse einer randomisierten Doppelblindpröfung mit reduzierten Tagesdosierungen von Diclofenac (75 mg Diclofenac versus 75 mg Diclofenac plus B-Vitamine) bei akute Lendenwirbelsulensyndromen. Klin Wochenschr. 1990;68:107–115. DOI: 10.1007/BF01646857.
11. Кукушкин М.Л. Витамины группы В (B1, B6, B12) в комплексной терапии болевых синдромов. Российский журнал боли. 2019;17(3):39–45. DOI: 10.25731/RASP.2019.03.31. [Kukushkin M.L. Vitamins of group B (B1, B6, B12) in complex therapy of pain syndromes. Russian journal of pain. 2019;17(3):39–45 (in Russ.)]. DOI: 10.25731/RASP.2019.03.31.
12. Geissler C., Powers H., Human Nutrition. 13th ed. Oxford: Oxford University Press; 2017.
13. Lanska DJ. Historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. Handb Clin Neurol. 2010;95:445–476. DOI: 10.1016/S0072-9752(08)02130-1.
14. Marashly E.T., Bohlega S.A. Riboflavin Has Neuroprotective Potential: Focus on Parkinson's Disease and Migraine. Front Neurol. 2017;8:333. DOI: 10.3389/fneur.2017.00333.
15. Grazzi L., Toppo C., D'Amico D. et al. Non-pharmacological approaches to headaches: non-invasive neuromodulation, nutraceuticals, and behavioral approaches. Int J Environ Res Public Health. 2021;18(4):1503. DOI: 10.3390/ijerph18041503.
16. Chen Y.S., Lee H.F., Tsai C.H. et al. Effect of Vitamin B2 supplementation on migraine prophylaxis: a systematic review and meta-analysis. Nutr Neurosci. 2022;25(9):1801–1812. DOI: 10.1080/1028415X.2021.1904542.
17. Maizels M., Blumenfeld A., Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885–890.
18. Manor J., Calame D., Gijavanekar C. et al. NAXE deficiency: A neurometabolic disorder of NAD(P)HX repair amenable for metabolic correction. Mol Genet Metab. 2022;136(2):101–110. DOI: 10.1016/j.ymgme.2022.04.003.
19. Hoane M.R., Akstulewicz S.L., Toppen J. Treatment with vitamin B3 improves functional recovery and reduces GFAP expression following traumatic brain injury in rats. J Neurotrauma. 2003;20(11):1189–1199. DOI: 10.1089/089771503770802871.
20. Kamat J.P., Devasagayam T.P.A. Nicotinamide (vitamin B3) as an effective antioxidant against oxidative damage in rat brain mitochondria. Redox Rep. 1999;4(4):179–184. DOI: 10.1179/135100099101534882.
21. Maiese K., Chong Z.Z. Nicotinamide: Necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol. Sci. 2003;24(5):228–232. DOI: 10.1016/S0165-6147(03)00078-6.
22. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington (DC): National Academies Press (US); 1998. PMID: 23193625.
23. Zempleni J., Suttie J.W., Gregory J.F. III, Stover P.J. Handbook of Vitamins: 5th ed. CRC Press; 2013:459–477. DOI: 10.1201/b15413.
24. Baskin D.S., Browning J.L., Pirozzolo F.J. et al. Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol. 1999;56(9):121–1123. DOI: 10.1001/archneur.56.9.1121.
25. Franco-Maside A., Caamaño J., Gómez M.J., Cacabelos R. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease. Methods Find. Exp Clin Pharmacol. 1994;16(8):597–607.
26. Биологические функции пантотеновой кислоты. Пантотеновая кислота и мозг. Новые возможности метаболической и диетической терапии. В кн.: Материалы международного симпозиума. Под ред. член-корр. А.Г. Мойсеèнок. Гродно; 2013. [Biological functions of pantothenic acid. Pantothenic acid and the brain. New opportunities for metabolic and dietary therapy. In: Proceedings of the international symposium. A.G. Moiseyonok, ed. Grodno; 2013 (in Russ.)].
27. Xu J., Patassini S., Begley P. et al. Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease. Biochem Biophys Res Commun. 2020;527(3):676–681. DOI: 10.1016/j.bbrc.2020.05.015.
28. Tahiliani A.G., Beinlich C.J. Pantothenic acid in health and disease. Vitam Horm. 1991;46:165–228. DOI: 10.1016/s0083-6729(08)60684-6.
29. Громова О.А., Торшин И.Ю., Гусев Е.И. Синергидные нейропротекторные эффекты тиамина, пиридоксина и цианокобаламина в рамках протеома человека. Фармакокинетика и фармакодинамика. 2017;(1):40–51. [Gromov O.A., Torshin I.Yu., Gusev E.I. Synergistic neuroprotective effects of thiamine, pyridoxine and cyanocobalamin on the level of human proteome. Pharmacokinetics and Pharmacodynamics. 2017;(1):40–51 (in Russ.)].
30. Clayton P.T. B(6)-responsive disorders: A model of vitamin dependency. J Inherit Metab Dis. 2006;29(2–3):317–326. DOI: 10.1007/s10545-005-0243-2.
31. Спиричев В.Б. Витамины, витаминоподобные и минеральные вещества: Справочник. М.: МЦФЭР; 2004. [Spirichev V.B. Vitamins, vitamin-like and mineral substances: Directory. M.: MCFR; 2004 (in Russ.)].
32. Mock D.M. Biotin: From Nutrition to Therapeutics. J Nutr. 2017;147(8):1487–1492. DOI: 10.3945/jn.116.238956.
33. Espiritu A.I., Remalante-Rayco P.P.M. High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials. Mult Scler Relat Disord. 2021;55:103159. DOI: 10.1016/j.msard.2021.103159.
34. Tourbah A., Lebrun-Frenay C., Edan G. et al. MS-SPI study group. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult Scler. 2016;22(13):1719–1731. DOI: 10.1177/1352458516667568.
35. Bizzarri M., Fuso A., Dinicola S. et al. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016;12(10):1181–96. DOI: 10.1080/17425255.2016.1206887.
36. Chatree S., Thongmaen N., Tantivejkul K. et al. Role of Inositols and Inositol Phosphates in Energy Metabolism. Molecules. 2020;25(21):5079. DOI: 10.3390/molecules25215079.
37. Zhao X., Xu M., Jorgenson K., Kong J. Neurochemical changes in patients with chronic low back pain detected by proton magnetic resonance spectroscopy: A systematic review. Neuroimage Clin. 2016;13:33–38. DOI: 10.1016/j.nicl.2016.11.006.
38. Ebara S. Nutritional role of folate. Congenit Anom. (Kyoto). 2017;57(5):138–141. DOI: https://doi.org/10.1111/cga.12233.
39. Stover P.J. Physiology of Folate and Vitamin B 12 in Health and Disease. Nutr Rev. 2004;62(6 Pt 2):S3–12; discussion S13. DOI: 10.1111/j.1753-4887.2004.tb00070.x.
40. Zheng W., Li W., Qi H. et al. Adjunctive folate for major mental disorders: A systematic review. J Affect Dis. 2020;267:123–130. DOI: 10.1016/j.jad.2020.01.096.
41. Werder S.F. Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat. 2010;6:159–195. DOI: 10.2147/NDT.S6564.
42. Conzade R., Koenig W., Heier M. et al. Prevalence and Predictors of Subclinical Micronutrient Deficiency in German Older Adults: Results from the Population-Based KORA-Age Study. Nutrients. 2017;9:1276. DOI: 10.3390/nu9121276.
43. Andres E., Loukili N.H., Noel E. et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251–259. DOI: 10.1503/cmaj.1031155.
44. Zarafonetis C.J. Therapeutic possibilities of para-amino-benzoic acid. Ann Intern Med. 1949;30(6):1188–1211. DOI: 10.7326/0003-4819-30-6-1188.
45. Торшин И.Ю., Громова О.А. О неврологических функциях и синергизме витаминов B1, B6, B12. Российский журнал боли. 2022;20(1):56–64. DOI: 10.17116/pain20222001156. [Torshin I.Yu., Gromova O.A. Neurological functions and synergism of vitamins B1, B6 and B12. Russian journal of pain. 2022;20(1):56–64 (in Russ.)]. DOI: 10.17116/pain20222001156.
46. Blundo C., Marin D., Ricci M. Vitamin B12 deficiency associated with symptoms of frontotemporal dementia. Neurol Sci. 2011;32:101–105. DOI: 10.1007/s10072-010-0419-x.
47. Bopp-Kistler I., Ruegger-Frey В., Grob D., Six P. Vitamin B12 deficiency in geriatrics. Praxis. 1999;88(45):1867–1875.
48. Roy B., Trivedi R., Garg R.K. et al. Assessment of functional and structural damage in brain parenchyma in patients with vitamin B12 deficiency: a longitudinal perfusion and diffusion tensor imaging study. Magn Reson Imaging. 2015;33(5):537–543. DOI: 10.1016/j.mri.2015.02.012.
49. Wolters M., Ströhle A., Hahn A. [Age-associated changes in the metabolism of vitamin B(12) and folic acid: prevalence, aetiopathogenesis and pathophysiological consequences]. Z Gerontol Geriatr. 2004;37(2):109–135 (in German). DOI: 10.1007/s00391-004-0169-6.
50. Баранцевич Е.Р., Яковлев А.А., Гаврилова Е.А. и др. Исследование эффективности и безопасности ступенчатой терапии нестероидными противовоспалительными препаратами и витаминами группы B у пациентов с острой дорсалгией. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(10):53–57. DOI: 10.17116/jnevro202112110167. [Barantsevich E.R., Yakovlev A.A., Gavrilova E.A. et al. Study of the clinical efficacy and safety of the scheme of step therapy of nonsteroidal anti-inflammatory drugs and a complex of B vitamins in patients with low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10):53–57 (in Russ.)]. DOI: 10.17116/jnevro202112110167.
51. Bruggemann G., Koehler C.O., Koch E.M.W. Ergebnisse einer Dop-pelblindprufung Diclofenac + Vitamin B1, B6, B12 versus Diclofenac bei Patienten mit akuten Beschwerden im Lendenwirbelsfulenbereich. Klin Wochenschr 1990;68:116–120. DOI: 10.1007/BF01646858.
52. Lettko M., Schwieger G., Pudel V. Ergebnisse einer Doppelblindstudie, Neurofenac gegen Diclofenac, zum Nachweis der additiven Wirksamkeit der B-Vitamine. Rheuma, Schmerz & Enzundung. 1986;8:22–30.
53. Mibielli M.A. et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin 2009;25(11):2589–2599. DOI: 10.3111/13696990903246911.
54. Jurna I. Analgesic and analgesia-potentiating action of B vitamins. Schmerz 1998;12(2):136–141. DOI: 10.1007/s004820050136.
55. Franca D.S., Souza A.L. B vitamins induce an antinociceptive effect in the acetic acid and formaldehyde models of nociception in mice. Eur J Pharmacol. 2001;421(3):157–164. DOI: 10.1016/S0014-2999(01)01038-X.
56. Еременко Н.Н. Место витаминов группы В и липоевой кислоты в фармакотерапии полинейропатии. РМЖ. 2015;12:674. [Eremenko N.N. The place of B vitamins and lipoic acid in the pharmacotherapy of polyneuropathy. RMJ. 2015;12:674 (in Russ.)].
57. Chiu C., Low T., Tey Y. et al. The efficacy and safety of intra-muscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomized controlled trial. Singapore Med J. 2011;52(12):868–873.
58. Dehghan M. Comparative effectiveness of B and E vitamins with diclofenac in reducing pain due to osteoarthritis of the knee. Med Arh. 2015;69(2):103–106. DOI: 10.5455/medarh.2015.69.103-106.
59. Левин О.С., Мосейкин И.А. Комплекс витаминов группы В (Мильгамма) в лечении дискогенной пояснично-крестцовой радикулопатии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2009;109(10):30–35. [Levin O.S., Moseikin I.A. Vitamin B complex (Milgamma) in the treatment of vertebrogenic lumbosacral radiculopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2009;109(10):30–35 (in Russ.)].
60. Alipour A.O., Sadeghi M., Khan Z.H. et al. Comparison of Analgesic Effects of B Vitamins and Diclofenac plus B Vitamins During General Anesthesia and PACU. Arch Anesth & Crit Care. 2015;1(2):42–45.
61. Márquez M., Guzman S., Soto H. Systemic Review on the Use of Diclofenac/B Complex as an Anti-Inflammatory Treatment with Pain Relief Effect for Patients with Acute Lower Back Pain. J Pain Relief. 2015;4:216-221. DOI: 10.4172/21670846.1000216.
62. Ponce-Monter H.A., Ortiz M.I., Garza-Hernández A.F. et al. Effect of diclofenac with B vitamins on the treatment of acute pain originated by lower-limb fracture and surgery. Pain Res Treat. 2012;2012:104782. DOI: 10.1155/2012/104782.
63. Schwieger G. Zur Frage der Rezidivprophylaxe von schmerzhaften rbelsäulensyndromen durch B-Vitamine. Ergebnisse einer randomisier-Witen Doppelblindstudie Neurobion forte (Vitamin B1, B6, B12) gegen Placebo. In: Zöllner N., Fassl H., Jurna I., eds. Klinische Bedeutung von Vitamin B1, B6, B12 in der Schmerztherapie. Steinkopff, Heidelberg. 1988:169–181. DOI: 10.1007/978-3-642-72427-5_16.
64. Shane B., Stokstad E.L. Vitamin B12-folate interrelationships. Annu Rev Nutr. 1985;5:115–141. DOI: 10.1146/annurev.nu.05.070185.000555.
65. Weir D.G., Scott J.M. Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull. 1999;55(3):669–682. DOI: 10.1258/0007142991902547.
66. Malouf M., Grimley E.J., Areosa S.A. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev. 2003;(4):CD004514. DOI: 10.1002/14651858.CD004514.
67. Kwok T., Wu Y., Lee J. et al. A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients. Clin Nutr. 2020;39(8):2399–2405. DOI: 10.1016/j.clnu.2019.11.005.
68. Wu Y., Smith A.D., Refsum H., Kwok T. Effectiveness of B Vitamins and Their Interactions with Aspirin in Improving Cognitive Functioning in Older People with Mild Cognitive Impairment: Pooled Post-Hoc Analyses of Two Randomized Trials. J Nutr Health Aging. 2021;25(10):1154–1160. DOI: 10.1007/s12603-021-1708-1.
69. Nogueira-de-Almeida C.A., Zotarelli-Filho I.J., Nogueira-de-Almeida M.E. et al. Neuronutrients and central nervous system: a systematic review. Cent Nerv Syst Agents Med Chem. 2023;23(1):1–12. DOI: 10.2174/1871524923666221121123937.
70. Ravi K.R., Lovekesh S., Amandeep T. et al. Role of Vitamins in Neurodegenerative Diseases: A Review, CNS & Neurological Disorders. Drug Targets. 2022;21(9):766–773. DOI: 10.2174/1871527320666211119122150.
71. Malan T.P. Jr, Porreca F. Lipid mediators regulating pain sensitivity. Prostaglandins Other Lipid Mediat. 2005;77(1–4):123–130. DOI: 10.1016/j.prostaglandins.2004.09.008.
72. Kennedy D.O. B Vitamins and the Brain: Mechanisms, Dose and Efficacy — A Review. Nutrients. 2016;8(2):68. DOI: 10.3390/nu8020068.
73. Hanna M., Jaqua E., Nguyen V., Clay J. B Vitamins: functions and uses in medicine. Perm J. 2022;26(2):89–97. DOI: 10.7812/TPP/21.204.
2. 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, аnd years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. DOI: 10.1016/S0140-6736(18)32279-7.
3. Верткин А.Л., Шамуилова М.М., Кнорринг Г.Ю. и др. Профилактика и лечение боли в спине: Консенсусы экспертов. Доктор.Ру. 2020;19(9):45–52. [Vertkin A.L., Shamuilova M.M., Knorring G.Yu. Prevention and Treatment of Back Pain: Experts' Consensus Recommendations. Doctor.Ru. 2020;19(9):45–52 (in Russ.)]. DOI: 10.31550/1727-2378-2020-19-9-45-52.
4. Самарцев И.Н., Живолупов С.А., Баранцевич Е.Р., Данилов А.Б. Оценка терапевтической эффективности Алфлутопа в комплексном лечении пациентов с хронической болью в нижней части спины (наблюдательное исследование ЦЕЙТНОТ). Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(2):24–30. DOI: 10.17116/jnevro202112102124. [Samartcev I.N., Zhivolupov S.A., Barantsevich E.R., Danilov AB. The evaluation of the efficacy of Alflutop in the complex treatment of patients with chronic lower back pain (the observational study ZEITNOT). Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2021;121(2):24–30 (in Russ.)]. DOI: 10.17116/jnevro202112102124.
5. Скоромец А.А., Гехт А.Б., Галанов Д.В. и др. Результаты международного фармако-эпидемиологического наблюдательного проекта по применению мидокалма для лечения болевых синдромов, сопровождающихся мышечным спазмом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;115(12):104–109. DOI: 10.17116/jnevro2015115112104-109. [Skoromets A.A., Guekht A.B., Galanov D.V. et al. The results of the multicenter pharmaco-epidemiological observational project on the use of mydocalm in the treatment of pain syndromes with the muscle spasm. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015;115(12):104–109 (in Russ.)]. DOI: 10.17116/jnevro2015115112104-109.
6. Верткин А.Л., Каратеев А.Е., Кукушкин М.Л. и др. Ведение пациентов с болью в спине для терапевтов и врачей общей практики (клинические рекомендации). Терапия. 2018;2(20):8–17. [Vyortkin A.L., Karateev A.E., Kukushkin M.L. et al. Curation of patients with back pain for physicians and general practitioners (Clinical recommendations).Therapy. 2018;2(20):8–17 (in Russ.)].
7. Каратеев А.Е., Лила А.М., Дыдыкина И.С. и др. Персонификация применения нестероидных противовоспалительных препаратов при скелетно-мышечных заболеваниях. Резолюция по результатам совещания экспертов от 13 декабря 2017 г. Медицинский совет. 2018;18:76-84. DOI: 10.21518/2079-701X-2018-18-76-84. [Karateev A.E., Lila A.M., Dydykina I.S. et al. Personalization of the use of non-steroidal anti-inflammatory drugs for musculoskeletal diseases. Resolution on the results of the Meeting of Experts of December 13, 2017. Medical Council. 2018;(18):76–84 (in Russ.)]. DOI: 10.21518/2079-701X-2018-18-76-84.
8. Кукушкин М.Л. Алгоритмы диагностики и лечения боли в спине. РМЖ. 2014;11:844–848. [Kukushkin M.L. Algorithms for diagnosing and treating back pain. RMJ. 2014;11:844–848 (in Russ.)].
9. Кнорринг Г.Ю., Алиев З.К. Комбинированная терапия болевых синдромов: обоснование и перспективы потенцирования эффектов. Медицинский алфавит. 2020;1(1):28–30. DOI: 10.33667/2078-5631-2020-1-28-30. [Knorring G.Yu., Aliev Z.K. Combined therapy of pain syndromes: rationale and prospects for potentiation of effects. Medical alphabet. 2020;1(1):28–30 (in Russ.)]. DOI: 10.33667/2078-5631-2020-1-28-30.
10. Kuhlwein A., Meyer H.J., Koehler C.O. Ersparung von Diclofenac durch B-Vitamine: Ergebnisse einer randomisierten Doppelblindpröfung mit reduzierten Tagesdosierungen von Diclofenac (75 mg Diclofenac versus 75 mg Diclofenac plus B-Vitamine) bei akute Lendenwirbelsulensyndromen. Klin Wochenschr. 1990;68:107–115. DOI: 10.1007/BF01646857.
11. Кукушкин М.Л. Витамины группы В (B1, B6, B12) в комплексной терапии болевых синдромов. Российский журнал боли. 2019;17(3):39–45. DOI: 10.25731/RASP.2019.03.31. [Kukushkin M.L. Vitamins of group B (B1, B6, B12) in complex therapy of pain syndromes. Russian journal of pain. 2019;17(3):39–45 (in Russ.)]. DOI: 10.25731/RASP.2019.03.31.
12. Geissler C., Powers H., Human Nutrition. 13th ed. Oxford: Oxford University Press; 2017.
13. Lanska DJ. Historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. Handb Clin Neurol. 2010;95:445–476. DOI: 10.1016/S0072-9752(08)02130-1.
14. Marashly E.T., Bohlega S.A. Riboflavin Has Neuroprotective Potential: Focus on Parkinson's Disease and Migraine. Front Neurol. 2017;8:333. DOI: 10.3389/fneur.2017.00333.
15. Grazzi L., Toppo C., D'Amico D. et al. Non-pharmacological approaches to headaches: non-invasive neuromodulation, nutraceuticals, and behavioral approaches. Int J Environ Res Public Health. 2021;18(4):1503. DOI: 10.3390/ijerph18041503.
16. Chen Y.S., Lee H.F., Tsai C.H. et al. Effect of Vitamin B2 supplementation on migraine prophylaxis: a systematic review and meta-analysis. Nutr Neurosci. 2022;25(9):1801–1812. DOI: 10.1080/1028415X.2021.1904542.
17. Maizels M., Blumenfeld A., Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885–890.
18. Manor J., Calame D., Gijavanekar C. et al. NAXE deficiency: A neurometabolic disorder of NAD(P)HX repair amenable for metabolic correction. Mol Genet Metab. 2022;136(2):101–110. DOI: 10.1016/j.ymgme.2022.04.003.
19. Hoane M.R., Akstulewicz S.L., Toppen J. Treatment with vitamin B3 improves functional recovery and reduces GFAP expression following traumatic brain injury in rats. J Neurotrauma. 2003;20(11):1189–1199. DOI: 10.1089/089771503770802871.
20. Kamat J.P., Devasagayam T.P.A. Nicotinamide (vitamin B3) as an effective antioxidant against oxidative damage in rat brain mitochondria. Redox Rep. 1999;4(4):179–184. DOI: 10.1179/135100099101534882.
21. Maiese K., Chong Z.Z. Nicotinamide: Necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol. Sci. 2003;24(5):228–232. DOI: 10.1016/S0165-6147(03)00078-6.
22. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington (DC): National Academies Press (US); 1998. PMID: 23193625.
23. Zempleni J., Suttie J.W., Gregory J.F. III, Stover P.J. Handbook of Vitamins: 5th ed. CRC Press; 2013:459–477. DOI: 10.1201/b15413.
24. Baskin D.S., Browning J.L., Pirozzolo F.J. et al. Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol. 1999;56(9):121–1123. DOI: 10.1001/archneur.56.9.1121.
25. Franco-Maside A., Caamaño J., Gómez M.J., Cacabelos R. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease. Methods Find. Exp Clin Pharmacol. 1994;16(8):597–607.
26. Биологические функции пантотеновой кислоты. Пантотеновая кислота и мозг. Новые возможности метаболической и диетической терапии. В кн.: Материалы международного симпозиума. Под ред. член-корр. А.Г. Мойсеèнок. Гродно; 2013. [Biological functions of pantothenic acid. Pantothenic acid and the brain. New opportunities for metabolic and dietary therapy. In: Proceedings of the international symposium. A.G. Moiseyonok, ed. Grodno; 2013 (in Russ.)].
27. Xu J., Patassini S., Begley P. et al. Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease. Biochem Biophys Res Commun. 2020;527(3):676–681. DOI: 10.1016/j.bbrc.2020.05.015.
28. Tahiliani A.G., Beinlich C.J. Pantothenic acid in health and disease. Vitam Horm. 1991;46:165–228. DOI: 10.1016/s0083-6729(08)60684-6.
29. Громова О.А., Торшин И.Ю., Гусев Е.И. Синергидные нейропротекторные эффекты тиамина, пиридоксина и цианокобаламина в рамках протеома человека. Фармакокинетика и фармакодинамика. 2017;(1):40–51. [Gromov O.A., Torshin I.Yu., Gusev E.I. Synergistic neuroprotective effects of thiamine, pyridoxine and cyanocobalamin on the level of human proteome. Pharmacokinetics and Pharmacodynamics. 2017;(1):40–51 (in Russ.)].
30. Clayton P.T. B(6)-responsive disorders: A model of vitamin dependency. J Inherit Metab Dis. 2006;29(2–3):317–326. DOI: 10.1007/s10545-005-0243-2.
31. Спиричев В.Б. Витамины, витаминоподобные и минеральные вещества: Справочник. М.: МЦФЭР; 2004. [Spirichev V.B. Vitamins, vitamin-like and mineral substances: Directory. M.: MCFR; 2004 (in Russ.)].
32. Mock D.M. Biotin: From Nutrition to Therapeutics. J Nutr. 2017;147(8):1487–1492. DOI: 10.3945/jn.116.238956.
33. Espiritu A.I., Remalante-Rayco P.P.M. High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials. Mult Scler Relat Disord. 2021;55:103159. DOI: 10.1016/j.msard.2021.103159.
34. Tourbah A., Lebrun-Frenay C., Edan G. et al. MS-SPI study group. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult Scler. 2016;22(13):1719–1731. DOI: 10.1177/1352458516667568.
35. Bizzarri M., Fuso A., Dinicola S. et al. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016;12(10):1181–96. DOI: 10.1080/17425255.2016.1206887.
36. Chatree S., Thongmaen N., Tantivejkul K. et al. Role of Inositols and Inositol Phosphates in Energy Metabolism. Molecules. 2020;25(21):5079. DOI: 10.3390/molecules25215079.
37. Zhao X., Xu M., Jorgenson K., Kong J. Neurochemical changes in patients with chronic low back pain detected by proton magnetic resonance spectroscopy: A systematic review. Neuroimage Clin. 2016;13:33–38. DOI: 10.1016/j.nicl.2016.11.006.
38. Ebara S. Nutritional role of folate. Congenit Anom. (Kyoto). 2017;57(5):138–141. DOI: https://doi.org/10.1111/cga.12233.
39. Stover P.J. Physiology of Folate and Vitamin B 12 in Health and Disease. Nutr Rev. 2004;62(6 Pt 2):S3–12; discussion S13. DOI: 10.1111/j.1753-4887.2004.tb00070.x.
40. Zheng W., Li W., Qi H. et al. Adjunctive folate for major mental disorders: A systematic review. J Affect Dis. 2020;267:123–130. DOI: 10.1016/j.jad.2020.01.096.
41. Werder S.F. Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat. 2010;6:159–195. DOI: 10.2147/NDT.S6564.
42. Conzade R., Koenig W., Heier M. et al. Prevalence and Predictors of Subclinical Micronutrient Deficiency in German Older Adults: Results from the Population-Based KORA-Age Study. Nutrients. 2017;9:1276. DOI: 10.3390/nu9121276.
43. Andres E., Loukili N.H., Noel E. et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251–259. DOI: 10.1503/cmaj.1031155.
44. Zarafonetis C.J. Therapeutic possibilities of para-amino-benzoic acid. Ann Intern Med. 1949;30(6):1188–1211. DOI: 10.7326/0003-4819-30-6-1188.
45. Торшин И.Ю., Громова О.А. О неврологических функциях и синергизме витаминов B1, B6, B12. Российский журнал боли. 2022;20(1):56–64. DOI: 10.17116/pain20222001156. [Torshin I.Yu., Gromova O.A. Neurological functions and synergism of vitamins B1, B6 and B12. Russian journal of pain. 2022;20(1):56–64 (in Russ.)]. DOI: 10.17116/pain20222001156.
46. Blundo C., Marin D., Ricci M. Vitamin B12 deficiency associated with symptoms of frontotemporal dementia. Neurol Sci. 2011;32:101–105. DOI: 10.1007/s10072-010-0419-x.
47. Bopp-Kistler I., Ruegger-Frey В., Grob D., Six P. Vitamin B12 deficiency in geriatrics. Praxis. 1999;88(45):1867–1875.
48. Roy B., Trivedi R., Garg R.K. et al. Assessment of functional and structural damage in brain parenchyma in patients with vitamin B12 deficiency: a longitudinal perfusion and diffusion tensor imaging study. Magn Reson Imaging. 2015;33(5):537–543. DOI: 10.1016/j.mri.2015.02.012.
49. Wolters M., Ströhle A., Hahn A. [Age-associated changes in the metabolism of vitamin B(12) and folic acid: prevalence, aetiopathogenesis and pathophysiological consequences]. Z Gerontol Geriatr. 2004;37(2):109–135 (in German). DOI: 10.1007/s00391-004-0169-6.
50. Баранцевич Е.Р., Яковлев А.А., Гаврилова Е.А. и др. Исследование эффективности и безопасности ступенчатой терапии нестероидными противовоспалительными препаратами и витаминами группы B у пациентов с острой дорсалгией. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(10):53–57. DOI: 10.17116/jnevro202112110167. [Barantsevich E.R., Yakovlev A.A., Gavrilova E.A. et al. Study of the clinical efficacy and safety of the scheme of step therapy of nonsteroidal anti-inflammatory drugs and a complex of B vitamins in patients with low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10):53–57 (in Russ.)]. DOI: 10.17116/jnevro202112110167.
51. Bruggemann G., Koehler C.O., Koch E.M.W. Ergebnisse einer Dop-pelblindprufung Diclofenac + Vitamin B1, B6, B12 versus Diclofenac bei Patienten mit akuten Beschwerden im Lendenwirbelsfulenbereich. Klin Wochenschr 1990;68:116–120. DOI: 10.1007/BF01646858.
52. Lettko M., Schwieger G., Pudel V. Ergebnisse einer Doppelblindstudie, Neurofenac gegen Diclofenac, zum Nachweis der additiven Wirksamkeit der B-Vitamine. Rheuma, Schmerz & Enzundung. 1986;8:22–30.
53. Mibielli M.A. et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin 2009;25(11):2589–2599. DOI: 10.3111/13696990903246911.
54. Jurna I. Analgesic and analgesia-potentiating action of B vitamins. Schmerz 1998;12(2):136–141. DOI: 10.1007/s004820050136.
55. Franca D.S., Souza A.L. B vitamins induce an antinociceptive effect in the acetic acid and formaldehyde models of nociception in mice. Eur J Pharmacol. 2001;421(3):157–164. DOI: 10.1016/S0014-2999(01)01038-X.
56. Еременко Н.Н. Место витаминов группы В и липоевой кислоты в фармакотерапии полинейропатии. РМЖ. 2015;12:674. [Eremenko N.N. The place of B vitamins and lipoic acid in the pharmacotherapy of polyneuropathy. RMJ. 2015;12:674 (in Russ.)].
57. Chiu C., Low T., Tey Y. et al. The efficacy and safety of intra-muscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomized controlled trial. Singapore Med J. 2011;52(12):868–873.
58. Dehghan M. Comparative effectiveness of B and E vitamins with diclofenac in reducing pain due to osteoarthritis of the knee. Med Arh. 2015;69(2):103–106. DOI: 10.5455/medarh.2015.69.103-106.
59. Левин О.С., Мосейкин И.А. Комплекс витаминов группы В (Мильгамма) в лечении дискогенной пояснично-крестцовой радикулопатии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2009;109(10):30–35. [Levin O.S., Moseikin I.A. Vitamin B complex (Milgamma) in the treatment of vertebrogenic lumbosacral radiculopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2009;109(10):30–35 (in Russ.)].
60. Alipour A.O., Sadeghi M., Khan Z.H. et al. Comparison of Analgesic Effects of B Vitamins and Diclofenac plus B Vitamins During General Anesthesia and PACU. Arch Anesth & Crit Care. 2015;1(2):42–45.
61. Márquez M., Guzman S., Soto H. Systemic Review on the Use of Diclofenac/B Complex as an Anti-Inflammatory Treatment with Pain Relief Effect for Patients with Acute Lower Back Pain. J Pain Relief. 2015;4:216-221. DOI: 10.4172/21670846.1000216.
62. Ponce-Monter H.A., Ortiz M.I., Garza-Hernández A.F. et al. Effect of diclofenac with B vitamins on the treatment of acute pain originated by lower-limb fracture and surgery. Pain Res Treat. 2012;2012:104782. DOI: 10.1155/2012/104782.
63. Schwieger G. Zur Frage der Rezidivprophylaxe von schmerzhaften rbelsäulensyndromen durch B-Vitamine. Ergebnisse einer randomisier-Witen Doppelblindstudie Neurobion forte (Vitamin B1, B6, B12) gegen Placebo. In: Zöllner N., Fassl H., Jurna I., eds. Klinische Bedeutung von Vitamin B1, B6, B12 in der Schmerztherapie. Steinkopff, Heidelberg. 1988:169–181. DOI: 10.1007/978-3-642-72427-5_16.
64. Shane B., Stokstad E.L. Vitamin B12-folate interrelationships. Annu Rev Nutr. 1985;5:115–141. DOI: 10.1146/annurev.nu.05.070185.000555.
65. Weir D.G., Scott J.M. Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull. 1999;55(3):669–682. DOI: 10.1258/0007142991902547.
66. Malouf M., Grimley E.J., Areosa S.A. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev. 2003;(4):CD004514. DOI: 10.1002/14651858.CD004514.
67. Kwok T., Wu Y., Lee J. et al. A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients. Clin Nutr. 2020;39(8):2399–2405. DOI: 10.1016/j.clnu.2019.11.005.
68. Wu Y., Smith A.D., Refsum H., Kwok T. Effectiveness of B Vitamins and Their Interactions with Aspirin in Improving Cognitive Functioning in Older People with Mild Cognitive Impairment: Pooled Post-Hoc Analyses of Two Randomized Trials. J Nutr Health Aging. 2021;25(10):1154–1160. DOI: 10.1007/s12603-021-1708-1.
69. Nogueira-de-Almeida C.A., Zotarelli-Filho I.J., Nogueira-de-Almeida M.E. et al. Neuronutrients and central nervous system: a systematic review. Cent Nerv Syst Agents Med Chem. 2023;23(1):1–12. DOI: 10.2174/1871524923666221121123937.
70. Ravi K.R., Lovekesh S., Amandeep T. et al. Role of Vitamins in Neurodegenerative Diseases: A Review, CNS & Neurological Disorders. Drug Targets. 2022;21(9):766–773. DOI: 10.2174/1871527320666211119122150.
71. Malan T.P. Jr, Porreca F. Lipid mediators regulating pain sensitivity. Prostaglandins Other Lipid Mediat. 2005;77(1–4):123–130. DOI: 10.1016/j.prostaglandins.2004.09.008.
72. Kennedy D.O. B Vitamins and the Brain: Mechanisms, Dose and Efficacy — A Review. Nutrients. 2016;8(2):68. DOI: 10.3390/nu8020068.
73. Hanna M., Jaqua E., Nguyen V., Clay J. B Vitamins: functions and uses in medicine. Perm J. 2022;26(2):89–97. DOI: 10.7812/TPP/21.204.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous article
Next article
